14Jan/14

Erlanger Announces Appointment Of Asad Zaman, MHA, As Transplant Service … – The Chattanoogan


The Chattanoogan

Erlanger Announces Appointment Of Asad Zaman, MHA, As Transplant Service
The Chattanoogan
the overall operation of end-stage renal care in our region. As the region’s only kidney transplant program, Asad will focus on providing more outreach to surrounding communities and educating patients about their local option for kidney

14Jan/14

Rexahn Pharma (RNN) Initiates Archexin Proof-of-Concept Study in RCC – StreetInsider.com (subscription)

Rexahn Pharma (RNN) Initiates Archexin Proof-of-Concept Study in RCC
StreetInsider.com (subscription)
The Phase IIa Archexin proof-of-concept clinical trial is a multi-center study designed to evaluate the efficacy of Archexin in combination with everolimus (Afinitor®) to treat metastatic RCC patients and will be conducted in two stages. Stage 1 will

and more »

14Jan/14

ST2 Identifies Hypertensive Patients Likely to Develop Heart Failure – PharmiWeb.com (press release)

ST2 Identifies Hypertensive Patients Likely to Develop Heart Failure
PharmiWeb.com (press release)
Critical Diagnostics announced today that a paper titled “The Effect of Left Ventricle Remodelling On Soluble ST2 in A Cohort of Hypertensive Subjects” published in Journal of Human Hypertension showed that the Company’s biomarker ST2was useful in not 

and more »